Online citations, reference lists, and bibliographies.
← Back to Search

Nanocarriers: Promising Vehicle For Bioactive Drugs.

M. Rawat, D. Singh, S. Saraf, S. Saraf
Published 2006 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Development of new delivery systems that deliver the potential drug specifically to the target site in order to meet the therapeutic needs of the patients at the required time and level remains the key challenge in the field of pharmaceutical biotechnology. Developments in this context to achieve desired goal has led to the evolution of the multidisciplinary field nanobiotechnology which involves the combination of two most promising technologies of 21st century--biotechnology and nanotechnology. Nanobiotechnology encompasses a wide array of different techniques to improve the delivery of biotech drugs, and nanoparticles offer the most suitable form whose properties can be tailored by chemical methods. This review highlights the different types of nanoparticulate delivery systems employed for biotech drugs in the field of molecular medicine with a short overlook at its applications and the probable associated drawbacks.
This paper references
10.1016/S0168-3659(01)00474-6
Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide.
S. Ramanathan (2001)
10.1021/CR940351U
Polymeric systems for controlled drug release.
K. Uhrich (1999)
10.1016/J.EJPB.2005.09.003
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
N. Pedersen (2006)
10.1016/J.TOXLET.2004.08.015
Effect of single wall carbon nanotubes on human HEK293 cells.
D. Cui (2005)
10.1016/S0928-0987(03)00019-8
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.
A. Sánchez (2003)
10.1016/J.COLSURFB.2003.08.014
Synthesis of a novel gelatin - carbon nanotubes hybrid hydrogel
H. Li (2004)
10.1038/sj.gt.3301318
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
H. Cohen (2000)
10.1016/S0014-3057(03)00100-9
Dendrimers: a new class of nanoscopic containers and delivery devices
Francesca Aulenta (2003)
10.1021/BM050144B
Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier.
J. N. Patton (2005)
10.1295/POLYMJ.17.117
A New Class of Polymers: Starburst-Dendritic Macromolecules
D. Tomalia (1985)
10.1517/17425247.2.5.791
Microparticles for oral delivery of vaccines
G. Mutwiri (2005)
10.1016/S0142-9612(99)00022-8
Functionalized nanoparticles for endotoxin binding in aqueous solutions.
R. Darkow (1999)
10.1557/MRS2000.123
Thermal-Barrier Coatings for Advanced Gas-Turbine Engines
D. Zhu (2000)
10.3109/10837459709022618
Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery.
N. Wang (1997)
10.1016/S0928-0987(02)00251-8
Nanosizing: a formulation approach for poorly-water-soluble compounds.
E. Merisko-Liversidge (2003)
10.1038/nrd1494
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1016/S1359-6446(02)02174-8
Using machines in cells.
J. Schmidt (2002)
10.1081/DDC-100101255
Self-Assembled Carbohydrate-Stabilized Ceramic Nanoparticles for the Parenteral Delivery of Insulin
A. K. Cherian (2000)
10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery.
S. Sershen (2000)
10.1111/j.1349-7006.2001.tb01099.x
Cisplatin‐incorporated Polymeric Micelles Eliminate Nephrotoxicity, While Maintaining Antitumor Activity
Y. Mizumura (2001)
10.1517/14712598.3.4.655
Nanotechnology and medicine
D. Emerich (2003)
10.1021/LA00094A013
Surface modification of colloidal silica
Rickey D. Badley (1990)
10.1023/A:1011922819926
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1615/CRITREVTHERDRUGCARRIERSYST.V22.I5.10
Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
S. Galindo-Rodriguez (2005)
10.1073/pnas.0931428100
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
V. Torchilin (2003)
10.6028/jres.109.041
Properties of Nanostructured Hydroxyapatite Prepared by a Spray Drying Technique
L. Chow (2004)
10.1007/0-306-47932-X_10
Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs.
N. Nishiyama (2003)
10.1016/S1461-5347(98)00024-8
Microparticulate delivery systems: potential drug/vaccine carriers via mucosal routes
A. M. Hillery (1998)
10.1103/PHYSREVLETT.78.4217
Plasmon Resonance Shifts of Au-Coated Au 2 S Nanoshells: Insight into Multicomponent Nanoparticle Growth
R. Averitt (1997)
10.1016/J.JCONREL.2004.06.016
Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier.
Mona Gupta (2004)
10.1016/J.ADDR.2004.03.002
BioMEMS: state-of-the-art in detection, opportunities and prospects.
R. Bashir (2004)
10.1016/J.ADDR.2004.09.005
Virosomes for antigen and DNA delivery.
T. Daemen (2005)
10.1021/BC010103M
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation.
O. L. Padilla De Jesús (2002)
10.1016/j.ddtec.2005.05.007
Smart polymeric micelles for gene and drug delivery.
N. Nishiyama (2005)
10.1016/S0939-6411(99)00039-9
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
10.1016/S1359-6446(03)02903-9
Nanotech approaches to drug delivery and imaging.
S. Sahoo (2003)
10.1016/S0168-3659(01)00218-8
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Y. Li (2001)
10.1016/J.JCONREL.2003.11.019
A self-assembled, modular DNA delivery system mediated by silica nanoparticles.
D. Luo (2004)
10.1016/S0169-409X(98)00039-8
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.
Allémann (1998)
10.1016/J.PRECISIONENG.2002.11.002
Nanotechnology and nanostructured materials: trends in carbon nanotubes
A. Mamalis (2004)
10.1016/S0142-9612(01)00362-3
Production of lipospheres as carriers for bioactive compounds.
R. Cortesi (2002)
10.1016/S0378-5173(98)00404-9
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
C. Olbrich (1999)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1016/j.addr.2012.09.015
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1016/0378-5173(96)04539-5
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
10.1016/S0168-3659(01)00506-5
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.
C. Olbrich (2001)
10.1016/S0168-3659(98)00017-0
Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin.
K. Akiyoshi (1998)
10.1016/S0968-0896(01)00149-3
Testosterone delivery using glutamide-based complex high axial ratio microstructures.
A. Goldstein (2001)
10.1089/AID.1996.12.1709
Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy.
R. Löbenberg (1996)
10.1039/B500681C
Multi-walled carbon nanotubes for plasmid delivery into Escherichia coli cells.
José Rojas-Chapana (2005)
10.1016/0168-3659(96)01342-9
Co-polymerised peptide particles (CPP) I: synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system
A. M. Hillery (1996)
10.1016/J.CHEMBIOL.2004.10.016
Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
Youngseon Choi (2005)
10.1016/S0956-5663(00)00056-7
Highly sensitive optical chip immunoassays in human serum.
B. Schneider (2000)
10.1089/OLI.1.1999.9.301
Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides.
I. Aynié (1999)
10.1038/nrd988
The emerging field of nanotube biotechnology
C. Martin (2003)
10.1016/S1389-0352(01)00027-7
Semi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnology.
C. Niemeyer (2001)
10.1016/S0378-5173(03)00377-6
Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies.
M. Bivas-Benita (2003)
10.1016/S0168-3659(99)00244-8
Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis.
I. Fishbein (2000)
10.1016/J.JCONREL.2004.08.027
Comparison of antisense oligonucleotide drug delivery systems.
J. Weyermann (2004)
10.1016/J.VACCINE.2003.12.032
Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
Praveen Elamanchili (2004)
10.1016/S0958-1669(03)00068-5
Nanotechnology: convergence with modern biology and medicine.
M. Roco (2003)
10.1016/J.JCONREL.2004.10.022
Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.
L. Ould-Ouali (2005)
10.1126/SCIENCE.1078192
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
R. Savić (2003)
10.1016/0378-5173(94)00324-X
Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery
L. Brannon-Peppas (1995)
10.1016/J.IJPHARM.2005.03.027
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor.
Y. Aktaş (2005)
10.1016/0378-5173(95)00098-4
Long acting injectable oxytetracycline-liposphere formulations
A. Domb (1995)
10.1016/S0169-409X(00)00118-6
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
10.1039/B108568A
A fluorescent PEBBLE nanosensor for intracellular free zinc.
J. P. Sumner (2002)
10.1016/S0169-409X(01)00222-8
Advanced drug delivery devices via self-assembly of amphiphilic block copolymers.
A. Rösler (2001)
10.1021/JA973849X
Nanometer Silica Particles Encapsulating Active Compounds: A Novel Ceramic Drug Carrier
T. K. Jain (1998)
10.1089/10430340360464660
Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
Y. Zhang (2003)
10.1021/BC025557D
Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin.
F. Kihara (2002)
10.1163/1568562041753106
Tissue responses to thermally-responsive hydrogel nanoparticles
H. Weng (2004)
10.1016/S0378-5173(02)00452-0
Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery.
I. Roy (2003)
10.2165/00003495-199700544-00004
Liposomes. Opportunities in drug delivery.
T. Allen (1997)
10.1016/S0168-3659(01)00299-1
Structure and design of polymeric surfactant-based drug delivery systems.
V. Torchilin (2001)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1002/BIT.1200
Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application.
A. Prokop (2002)
10.1016/S0006-291X(02)00445-X
Cellular localisation of a water-soluble fullerene derivative.
Sarah Foley (2002)
10.1016/J.BIOMATERIALS.2003.10.063
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
T. Kim (2004)
Biological , medical and health applications
C. RocoM. (2005)
10.3109/10611869308998760
Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats.
G. Borchard (1993)
10.1016/0378-5173(86)90081-5
Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration
A. Smith (1986)
10.1016/J.CHEMBIOL.2003.09.011
Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses.
D. Pantarotto (2003)
10.3390/10010065
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
F. Delié (2005)
10.1016/S0006-2952(99)00316-0
Biomimetic transport and rational drug delivery.
D. F. Ranney (2000)
10.1063/1.1815053
Diffusion of carbon nanotubes with single-molecule fluorescence microscopy
Q. I. L. Lu (2004)
10.1016/J.IJPHARM.2004.07.019
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
J. Kipp (2004)
10.1016/S0939-6411(99)00075-2
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
V. Jenning (2000)
10.1016/S0927-7765(99)00080-6
Poly(ethylene glycol)–polyethyleneimine NanoGel™ particles: novel drug delivery systems for antisense oligonucleotides
S. Vinogradov (1999)
10.1016/S0378-5173(02)00072-8
Enhanced drug dissolution using evaporative precipitation into aqueous solution.
Marazban Sarkari (2002)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1111/j.2042-7158.1991.tb05437.x
The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats
C. Michel (1991)



This paper is referenced by
10.22270/JDDT.V3I5.616
NANOTECHNOLOGY IN CANCER THERAPY
V. Dhiman (2013)
10.1016/J.JCONREL.2007.10.027
Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
E. Briones (2008)
From bench to bedside: the growing use of translational research in cancer medicine.
Erin M. Goldblatt (2010)
10.1117/12.2213744
Label-free imaging of gold nanoparticles in single live cells by photoacoustic microscopy
C. Tian (2016)
10.5530/pj.2020.12.51
Synthesis, characterization, and cytotoxicity evaluation of gallic acid nanoparticles towards breast T47D cancer cells
Ade Arsianti (2020)
UNIVERSIDADE FEDERAL DE SANTA CATARINA CENTRO DE CIÊNCIAS BIOLÓGICAS PROGRAMA DE PÓS-GRADUAÇÃO EM FARMACOLOGIA
S. Guzzi (2011)
10.1016/j.ejps.2010.09.004
Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior.
Vassilios Karavelidis (2010)
10.1021/bp060348j
Nanoparticle‐Mediated Drug Delivery and Gene Therapy
S. Jin (2007)
10.1080/21691401.2016.1198363
Novel catalase loaded nanocores for the treatment of inflammatory bowel diseases
A. Parihar (2017)
Nimesulide-Serratiopeptidase Sustained Release Microparticles - Combined Formulation and In Vitro Characterization Nimesulid i serratiopeptydaza - preparat złożony w postaci mikrocząsteczek o przedłużonym uwalnianiu - charakterystyka in vitro
Shujaat Khan (2011)
Zastosowanie nanonośników w medycynie
Justyna Siemieniec (2013)
10.2174/1568009615666150311100610
Review on triggered liposomal drug delivery with a focus on ultrasound.
Hesham G. Moussa (2015)
10.4018/978-1-5225-0610-2.CH005
Microbial Nanotechnology: Mycofabrication of Nanoparticles and Their Novel Applications
Vadlapudi Varahalarao (2017)
RATIONAL DESIGN OF NANOCARRIERS WITH ENHANCED CARRIER-DRUGINTERACTION FOR IMPROVED CANCER THERAPY
Peng Zhang (2015)
10.1080/14686996.2018.1528850
Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment
L. Li (2018)
10.1081/e-ebpp-120052264
Micelles: Polymeric and Lipid-Core Drug Delivery Systems
T. Musacchio (2015)
10.1016/j.biopha.2018.07.156
Understanding the prospective of nano-formulations towards the treatment of psoriasis.
M. Pradhan (2018)
Chapter 5 Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
A. Ahangari (2017)
10.1007/s11192-018-2831-6
How R&D partner diversity influences innovation performance: an empirical study in the nano-biopharmaceutical field
Guiyang Zhang (2018)
10.1016/j.jconrel.2009.05.013
Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
S. Papadimitriou (2009)
10.3109/03639041003598960
Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study
Marila Crivellaro Lay Marchiori (2010)
10.1039/C1SM05501A
Modeling and simulation of polyacrylic acid/protamine nanoparticle precipitation
Andreas Eitzlmayr (2011)
10.1021/nn102845t
Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with α-tocopherol-ascorbic acid surfactant.
C. Astete (2011)
10.14232/phd.1516
Innovative pharmaceutical formulations and excipients for nasal delivery of drugs to target the systemic circulation
Kürti Levente (2012)
10.3390/ph6111361
Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes
Mónica Rivera Díaz (2013)
10.1158/1078-0432.CCR-07-1441
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
10.14288/1.0228622
Progesterone-binding modified hyperbranched polyglycerols : synthesis, characterization and biological assessment
Mahsa Alizadeh Noghani (2016)
10.1016/j.drudis.2011.01.007
Antiangiogenic therapy using nanotechnological-based delivery system.
J. Kanwar (2011)
THESE DE L'UNIVERSITE DE LYON
C. Lyon (2010)
10.3109/07388551.2013.819484
Metallic nanoparticles: microbial synthesis and unique properties for biotechnological applications, bioavailability and biotransformation
Luciana Pereira (2015)
10.1021/acs.molpharmaceut.6b00207
Indocyanine Green-Loaded Liposomes for Light-Triggered Drug Release.
T. Lajunen (2016)
10.15517/RBT.V56I3.5728
Caracterización de bordes de bosque altoandino e implicaciones para la restauración ecológica en la Reserva Forestal de Cogua (Colombia)
Alba Lucía Montenegro (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar